Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents
about
Chemoresistance and targeted therapies in ovarian and endometrial cancersSurgical management of early endometrial cancer: an update and proposal of a therapeutic algorithmEffect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells.Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancersEnolase-1 is a therapeutic target in endometrial carcinoma.Impact of middle and lower jugular neck dissection on supraclavicular lymph node metastasis from endometrial carcinomaAKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers.Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients.Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.The clinical management of inoperable endometrial carcinoma.Enhancement of adriamycin cytotoxicity by sodium butyrate involves hTERT downmodulation-mediated apoptosis in human uterine cancer cells.Expression of CD133 in endometrial cancer cells and its implications.Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.Clinical Behavior and Treatment of Endometrial Cancer.α-Chaconine and α-Solanine Inhibit RL95-2 Endometrium Cancer Cell Proliferation by Reducing Expression of Akt (Ser473) and ERα (Ser167).MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells
P2860
Q28073246-D1E0978F-DFB1-43A9-B181-FE89E163D83FQ34062135-08E0D270-E3DF-4368-B5AE-4531B9ACE6A5Q34731333-15ACD23E-72D4-44A5-8D87-8101C8406F86Q35564030-149FA4A9-0372-4133-9E8D-14131FBD3395Q36021076-90895F7E-ADA9-4108-81B7-8D47AE8856FBQ36125584-F65CB8BF-2ECF-43B6-9F8B-1D366FEDCC4CQ36788196-97D436CB-0D10-4E29-8815-745547BCC288Q37016586-7B2CF129-B00D-4BEC-84C2-6F78112BB146Q37209603-B7481E90-8E79-4674-B760-49DA0774F745Q37716446-37C15666-443F-4EC8-8224-376271E7A6A0Q38783340-B4BFF43C-CBF1-4B4E-A8F4-97A5B362A890Q39202703-DDB2557A-22AD-4420-9F93-EC2162F464DFQ41439970-52E21766-05E8-4304-A395-9A076AA30CFAQ44187810-1A21CB6C-155B-42C1-9328-718B15E275ACQ45932069-EDB2C74F-CB72-4ADD-899C-C22552B1A1C3Q47736935-D800EAE2-BB72-41EC-A982-FE22892AF2D1Q48373900-FB89E891-EE10-45C0-B2D9-5EEDE31CC07CQ49657822-2432D425-E39F-4608-A1E2-1A0BD419428DQ54011680-6F2B586F-5AEE-40CE-BF3B-1848A230FEC2Q55498690-4E743A97-27C7-43F0-B4A2-1762D2B72238Q57786973-29E5FAEC-3AA5-4B9E-AF31-A1D886454A9B
P2860
Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Endometrial carcinoma: a revie ...... and the search for new agents
@ast
Endometrial carcinoma: a revie ...... and the search for new agents
@en
type
label
Endometrial carcinoma: a revie ...... and the search for new agents
@ast
Endometrial carcinoma: a revie ...... and the search for new agents
@en
prefLabel
Endometrial carcinoma: a revie ...... and the search for new agents
@ast
Endometrial carcinoma: a revie ...... and the search for new agents
@en
P2860
P921
P1433
P1476
Endometrial carcinoma: a revie ...... and the search for new agents
@en
P2093
D Scott McMeekin
Katherine M Moxley
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0087
P577
2010-10-07T00:00:00Z